Detalhe da pesquisa
1.
Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy.
Hum Mol Genet
; 33(10): 872-883, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340007
2.
Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
Hum Mol Genet
; 33(8): 698-708, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268317
3.
Human DUX4 and porcine DUXC activate similar early embryonic programs in pig muscle cells: implications for preclinical models of FSHD.
Hum Mol Genet
; 32(11): 1864-1874, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728804
4.
The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy.
Annu Rev Genomics Hum Genet
; 20: 265-291, 2019 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018108
5.
Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies.
Int J Mol Sci
; 21(7)2020 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32290091
6.
Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy.
Mol Ther
; 26(7): 1797-1807, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29759937
7.
CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.
Mol Ther
; 24(3): 527-35, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527377
8.
The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.
Antimicrob Agents Chemother
; 59(3): 1534-41, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25534740
9.
Myeloid cell 5-lipoxygenase activating protein modulates the response to vascular injury.
Circ Res
; 112(3): 432-40, 2013 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23250985
10.
Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.
Hum Mol Genet
; 21(20): 4419-30, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22798623
11.
Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis.
Genome Res
; 21(8): 1313-27, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21636662
12.
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing.
Nat Genet
; 37(3): 254-64, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15696166
13.
BioQ: tracing experimental origins in public genomic databases using a novel data provenance model.
Bioinformatics
; 28(8): 1189-91, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22426342
14.
Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial design.
bioRxiv
; 2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865168
15.
Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury.
Circulation
; 123(6): 631-9, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21282500
16.
Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.
J Cell Sci
; 123(Pt 7): 1116-23, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20215405
17.
mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia.
FASEB J
; 25(6): 1922-33, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21368105
18.
Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.
Differentiation
; 81(2): 107-18, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20970242
19.
FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?
J Pers Med
; 12(6)2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743650
20.
Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy.
J Neuromuscul Dis
; 9(1): 83-93, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459413